Table 1.
Baseline characteristics of 50 inmates treated for chronic HCV infection at national institute for infectious diseases L. Spallanzani, 2006-2009
| Characteristics |
Treated |
|
|---|---|---|
| N | % | |
| All |
50 |
|
|
Age |
|
|
| Median (IQR) |
39 (34–43) |
|
| <35 |
15 |
30.0 |
| 35-44 |
25 |
50.0 |
| ≥45 |
10 |
20.0 |
|
Race |
|
|
| Caucasian |
46 |
92.0 |
| African |
4 |
8.0 |
| BMI |
|
|
| <25 |
24 |
48.0 |
| ≥25 |
26 |
52.0 |
|
IVDU |
|
|
| Yes |
34 |
68.0 |
| No |
16 |
32.0 |
|
Biopsy staging (Metavir) |
|
|
| F1-F2 |
37 |
74.0 |
| F3-F4 |
13 |
26.0 |
|
ALT (IU/L) |
|
|
| <60 |
10 |
20.0 |
| ≥60 |
40 |
80.0 |
|
HCV-RNA (mU/ml) |
|
|
| <6x105 |
18 |
36.0 |
| ≥6x105 |
32 |
64.0 |
|
HCV genotype |
|
|
| 1 |
25 |
50.0 |
| Other than 1 |
25 |
50.0 |
|
HIV Ab |
3 |
6.0 |
| Positive |
47 | 94.0 |
| Negative | ||